Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8137695 Polyconjugates for in vivo delivery of polynucleotides
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
August 17, 2007
0
Date of Patent
March 20, 2012
0
Patent Application Number
11840468
0
Patent Citations Received
US Patent 12116573 Targeting ligands for therapeutic compounds
0
US Patent 11712478 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
US Patent 11851655 Compositions and methods for modulating apolipoprotein (a) expression
0
US Patent 11872287 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
US Patent 11912779 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
US Patent 12013403 Compositions and methods for detection of SMN protein in a subject and treatment of a subject
0
US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
Patent Inventor Names
Jon A. Wolff
0
So Wong
0
James E. Hagstrom
0
Jason Klein
0
Sean D. Monahan
0
Darren H. Wakefield
0
David B. Rozema
0
David L. Lewis
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
8137695
0
Patent Primary Examiner
Richard Schnizer
0
Find more entities like US Patent 8137695 Polyconjugates for in vivo delivery of polynucleotides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE